X0303 4 2011-04-25 0 0001131554 SYNCHRONOSS TECHNOLOGIES INC SNCR 0001363345 McCormick James M VERTEK CORPORATION 463 MOUNTAIN VIEW DRIVE COLCHESTER VT 05446 1 0 1 0 Common Stock 2011-04-25 4 S 0 12500 31.78 D 404693 I By GRAT Common Stock 2011-04-26 4 S 0 12500 31.30 D 392193 I By GRAT Common Stock 2011-04-27 4 S 0 12500 30.88 D 379693 I By GRAT Common Stock 1899655 D Common Stock 1988000 I by Vertek Corporation Common Stock 1000000 I BY GRAT The weighted average sales price is reported as stock sales were aggregated for reporting purposes. The per share transation price ranged from $31.59 to $32.12. The reporting person will provide, upon request from an appropriate party, the pre share sales volume and prices. These shares were previously reported as directly beneficially owned but were contributed to a grantor retained annuity trust on June 11, 2008. Reporting Person is the sole trustee of the trust The weighted average sales price is reported as stock sales were aggregated for reporting purposes. The per share transation price ranged from $30.66 to $31.99. The reporting person will provide, upon request from an appropriate party, the pre share sales volume and prices. The weighted average sales price is reported as stock sales were aggregated for reporting purposes. The per share transation price ranged from $30.46 to $31.25. The reporting person will provide, upon request from an appropriate party, the pre share sales volume and prices. The Reporting Person is the Chief Executive Officer and sole stockholder of Vertek Corporation. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in the report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 for any other purpose. These shares were previously reported as directly beneficially owned but were contributed to a grantor retained annuity trust on May 13, 2010. ***All of the sales reported on this Form were effected pursuant to an approved Rule 10b5-1 trading plan.*** /s/ James M. McCormick 2011-04-27